You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

paroxysmal nocturnal hemoglobinuria (PNH)

Showing 26 - 50 of 1,414
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (OMS906 Study Drug - 3 mg/kg, OMS906 Study Drug - 5 mg/kg, Ravulizumab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • OMS906 Study Drug - 3 mg/kg
  • +2 more
  • Aachen, Germany
  • +4 more
Jul 25, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Iptacopan (LNP023))

Active, not recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Iptacopan (LNP023)
  • Tianjin, Tianjin, China
  • +11 more
Nov 21, 2022

Paroxysmal Hemoglobinuria, Nocturnal Trial in Worldwide (Crovalimab, Placebo)

Active, not recruiting
  • Paroxysmal Hemoglobinuria, Nocturnal
  • Paris, France
  • +18 more
Dec 5, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in United States (Pegcetacoplan)

No longer available
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Jacksonville, Florida
  • +3 more
Jun 2, 2021

Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (APL-2)

Completed
Has Results
  • Paroxysmal Nocturnal Hemoglobinuria
  • Cali, Colombia
  • +29 more
Oct 14, 2022

Paroxysmal Nocturnal Hemoglobinuria Trial in China

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
    • Hefei, Anhui, China
    • +23 more
    Nov 23, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Nov 18, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (ABP 959, Eculizumab)

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria
    • Atlanta, Georgia
    • +23 more
    Nov 3, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Iptacopan)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Brno - Bohunice, Czechia
    • +30 more
    Jul 29, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Ravulizumab, Eculizumab)

    Completed
    Has Results
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Ravulizumab
    • Eculizumab
    • Duarte, California
    • +48 more
    Jul 14, 2022

    Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (REGN3918)

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • Sha Tin, Hong Kong
    • +11 more
    Jul 13, 2021

    Paroxysmal Nocturnal Hemoglobinuria Trial in Austria, South Africa, United Kingdom (BCX9930, Placebo)

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria
    • Vienna, Austria
    • +3 more
    Feb 15, 2022

    Evaluate the Impact of Eculizumab in Korean PNH Patients

    Completed
    • PNH
      • Seoul, Korea, Republic of
        Handok
      Apr 14, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

      Available
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Aug 31, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial in Kyiv (OMS906 study drug)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • OMS906 study drug
      • Kyiv, Ukraine
        Omeros Investigational Site
      May 25, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Pegcetacoplan, Soliris)

      Completed
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria
      • Los Angeles, California
      • +52 more
      Mar 1, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Bloemfontein, Cape Town, Pretoria (BCX10013)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Bloemfontein, South Africa
      • +2 more
      Oct 20, 2023

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (LNP023, Eculizumab, Ravulizumab)

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Duarte, California
      • +39 more
      Jan 13, 2023

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Pegcetacoplan)

      Completed
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria
      • Hong Kong, Hong Kong
      • +6 more
      Dec 14, 2020

      Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • Anti-C5 antibody treatment
      • Paris, France
        AP-HP Hôpital Saint Louis
      Apr 24, 2023

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Almaty, Vilnius, Colombo (rVA576, Standard of care (SOC))

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Almaty, Microdistrict Kalkaman, Kazakhstan
      • +2 more
      Nov 3, 2020

      Pharmacodynamics of Eculizumab in Paroxysmal Nocturnal

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • +2 more
      • Blood collection for measurement of eculizumab peak concentrations
      • Nijmegen, Netherlands
        Radboudumc
      Aug 23, 2022

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in United States (Pegcetacoplan)

      Completed
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Los Angeles, California
      • +6 more
      Dec 14, 2020

      Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • +3 more
        • London, Ontario, Canada
          London Health Sciences Centre
        May 10, 2022

        Paroxysmal Nocturnal Hemoglobinuria, Marchiafava-Micheli Syndrome, Paroxysmal Hemoglobinuria Trial in Moscow, Saint Petersburg,

        Completed
        • Paroxysmal Nocturnal Hemoglobinuria
        • +2 more
        • Elizaria®
        • Soliris®
        • Moscow, Russian Federation
        • +3 more
        Aug 27, 2021